Another one of the hottest biotech growth stocks to look into is Reata Pharmaceuticals).

Source: https://investorplace.com/2023/03/the-3-best-biotech-growth-stocks-to-buy/

Cantor Fitzgerald cut Reata Pharmaceuticals from an “overweight” rating to a “neutral” rating in a research note on Friday.

Source: https://www.etfdailynews.com/2023/07/30/reata-pharmaceuticals-nasdaqreta-downgraded-by-guggenheim/

Finally, HighMark Wealth Management LLC grew its stake in Reata Pharmaceuticals by 119.7% during the first quarter.

Source: https://www.americanbankingnews.com/2023/09/12/24800-shares-in-reata-pharmaceuticals-inc-nasdaqreta-purchased-by-bridger-management-llc.html

Reata Pharmaceuticals is an intriguing company because it has highly promising lead drugs (Bardo and Oma).

Source: https://seekingalpha.com/article/4571497-reata-pharmaceuticals-binary-catalyst-unlocking?source=feed_all_articles